Potential genetic mechanisms driving B/myeloid conversion in patients with follicular lymphoma and Langerhans cell neoplasms

References

• Roulland S, Navarro J-M, Grenot P, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med. 2006;203(11):2425–2431. doi:10.1084/jem.20061292
   PubMed Web of Science ®Google Scholar
• Liu Y, Hernandez AM, Shibata D, et al. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A. 1994;91(19):8910–8914. doi:10.1073/pnas.91.19.8910
   PubMed Web of Science ®Google Scholar
• Sungalee S, Mamessier E, Morgado E, et al. Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. J Clin Invest. 2014;124(12):5337–5351. doi:10.1172/JCI72415
   PubMed Web of Science ®Google Scholar
• Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997;29(3):157–166. doi:10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C
   PubMedGoogle Scholar
• Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719. Epub 2022 Jun 22. PMID: 35732831; PMCID: PMC9252913. doi:10.1038/s41375-022-01613-1
   PubMed Web of Science ®Google Scholar
• Risdall RJ, Dehner LP, Duray P, et al. Histiocytosis X (Langerhans’ cell histiocytosis). Prognostic role of histopathology. Arch Pathol Lab Med. 1983;107(2):59–63. FebPMID: 6600606.
   PubMed Web of Science ®Google Scholar
• Chikwava K, Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol. 2004;7(6):607–614. doi:10.1007/s10024-004-3027-z
   PubMed Web of Science ®Google Scholar
• Allen CE, Li L, Peters TL, et al. Cell-specific gene expression in langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal langerhans cells. J Immunol. 2010;184(8):4557–4567. doi:10.4049/jimmunol.0902336
   PubMed Web of Science ®Google Scholar
• Badalian-Very G, Vergilio J-A, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919–1923. Sep 16 doi:10.1182/blood-2010-04-279083
   PubMed Web of Science ®Google Scholar
• Chakraborty R, Hampton OA, Shen X, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a Central role for ERK activation in LCH pathogenesis. Blood. 2014;124(19):3007–3015. Nov 6 doi:10.1182/blood-2014-05-577825
   PubMed Web of Science ®Google Scholar
• Brown NA, Furtado LV, Betz BL, et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E–negative Langerhans cell histiocytosis. Blood. 2014;124(10):1655–1658. doi:10.1182/blood-2014-05-577361
   PubMed Web of Science ®Google Scholar
• Alayed K, Medeiros LJ, Patel KP, et al. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol. 2016;52:61–67. Epub 2016 Feb 1. PMID: 26980021. doi:10.1016/j.humpath.2015.12.029
   PubMed Web of Science ®Google Scholar
• Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med. 2018;379(9):856–868. doi:10.1056/NEJMra1607548
   PubMed Web of Science ®Google Scholar
• Cai D, Chen W, Jaffe R, et al. Langerhans cell sarcoma arising from chronic lymphocytic lymphoma/small lymphocytic leukemia: lineage analysis and braf v600e mutation study. N Am J Med Sci. 2013;5(6):386–391. doi:10.4103/1947-2714.114172
   PubMedGoogle Scholar
• Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111(12):5433–5439. doi:10.1182/blood-2007-11-124792
   PubMed Web of Science ®Google Scholar
• Ratei R, Hummel M, Anagnostopoulos I, et al. Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans’ cell sarcoma: evidence for hematopoietic plasticity. Haematologica. 2010;95(9):1461–1466. doi:10.3324/haematol.2009.021212
   PubMed Web of Science ®Google Scholar
• Shao H, Xi L, Raffeld M, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24(11):1421–1432. doi:10.1038/modpathol.2011.102
   PubMed Web of Science ®Google Scholar
• Feldman AL, Minniti C, Santi M, et al. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5(4):248–250. doi:10.1016/S1470-2045(04)01428-7
   PubMed Web of Science ®Google Scholar
• Feldman AL, Berthold F, Arceci RJ, et al. Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 2005;6(6):435–437. doi:10.1016/S1470-2045(05)70211-4
   PubMed Web of Science ®Google Scholar
• Tashakori M, Thakral B, Tang G, et al. From the archives of MD Anderson Cancer Center: a case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature. Ann Diagn Pathol. 2021;52:151720. doi:10.1016/j.anndiagpath.2021.151720
   PubMed Web of Science ®Google Scholar
• Egan C, Lack J, Skarshaug S, et al. The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Mod Pathol. 2020;34(2):336–347. doi:10.1038/s41379-020-00673-x
   PubMed Web of Science ®Google Scholar
• Feldman AL. Clonal relationships between malignant lymphomas and histiocytic/dendritic cell tumors. Surg Pathol Clin. 2013;6(4):619–629. doi:10.1016/j.path.2013.08.003
   PubMedGoogle Scholar
• Kumar R, Khan SP, Joshi D-D, et al. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer. 2010;56(2):307–310. doi:10.1002/pbc.22810
   Web of Science ®Google Scholar
• Buser L, Bihl M, Rufle A, et al. Unique composite hematolymphoid tumor consisting of a Pro-T lymphoblastic lymphoma and an indeterminate dendritic cell tumor: evidence for divergent common progenitor cell differentiation. Pathobiology. 2014;81(4):199–205. doi:10.1159/000365396
   PubMed Web of Science ®Google Scholar
• Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117(5):663–676. doi:10.1016/s0092-8674(04)00419-2
   PubMed Web of Science ®Google Scholar
• Graf T. Historical origins of transdifferentiation and reprogramming. Cell Stem Cell. 2011;9(6):504–516. doi:10.1016/j.stem.2011.11.012
   PubMed Web of Science ®Google Scholar
• Xiu Y, Dong Q, Fu L, et al. Coactivation of NF-κB and notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion. Blood. 2020;135(2):108–120. doi:10.1182/blood.2019001438
   PubMed Web of Science ®Google Scholar
• Xiao W, Amador C, Cook JR, et al. B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy. Am J Clin Pathol. 2023;159(6):522–537. doi:10.1093/ajcp/aqad022
   PubMed Web of Science ®Google Scholar
• Skala SL, Ye JC, Stumph J, et al. Combined tumors in hematolymphoid neoplasms: case series of histiocytic and Langerhans cell sarcomas arising from low-grade B-cell lymphoma. Clin Pathol. 2019;12:2632010X19878410. Jandoi:10.1177/2632010X19878410
   PubMed Web of Science ®Google Scholar
• Green MR, Gentles AJ, Nair RV, et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood. 2013;121(9):1604–1611. doi:10.1182/blood-2012-09-457283
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6(1):130–140. doi:10.1016/j.celrep.2013.12.027
   PubMed Web of Science ®Google Scholar
• Choi SM, Andea AA, Wang M, et al. KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma. Diagn Pathol. 2018;13(1):78. doi:10.1186/s13000-018-0758-0
   PubMedGoogle Scholar